Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth
Fiona H. Tan(The Royal Melbourne Hospital), Rodney B. Luwor(The Royal Melbourne Hospital)
Cited by 25
Related Papers
<p>Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies</p>
|OncoTargets and Therapy|2019|197
Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo
|Oncogene|2012|84